Zydus Wellness Limited has appointed Dr. Shyam Ramakrishnan as its Chief Scientific Officer, effective July 1, 2026, strengthening its senior management leadership. The appointment follows a recommendation by the Nomination and Remuneration Committee and was approved by the Board of Directors. Dr. Ramakrishnan joins the organization on a full-time contract basis, bringing extensive expertise in translational science and innovation platform development.

The disclosure was made to the exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the requisite details as stipulated by the SEBI Master Circular dated January 30, 2026. The appointment is effective immediately from the start of July 2026.

Dr. Shyam Ramakrishnan holds a PhD in Biological Chemistry & Genetics from the University of Texas. He has completed postdoctoral fellowships at Harvard Medical School and Hoffmann-La Roche. His academic background provides a strong foundation for his role in leading scientific strategy at zydus wellness .

Professional Background

Dr. Ramakrishnan brings over 25 years of experience across nutrition, dietary supplements, beauty, personal care, and functional foods. His career spans leadership roles in major organizations across the US, India, Southeast Asia, and other international markets. He has specialized in translational science, clinical research, bioinformatics, and innovation platform development.

Prior to this appointment, he served in key leadership positions with Hill's Pet Nutrition, The Himalaya Drug Company, ITC Ltd., and Amway in the United States, Southeast Asia, and Brazil. His experience includes leading large cross-functional teams and driving innovation in the consumer health and wellness sectors.

Appointment Details

Zydus Wellness International DMCC (ZWID), a wholly owned subsidiary of Zydus Wellness, has incorporated a step-down subsidiary named Zydus Wellness General Trading DWC-LLC (ZWGTL) in Dubai, UAE. The Certificate of Incorporation was received on June 30, 2026, at 11:33 a.m. IST. The strategic move aims to drive business expansion in the food and nutrition, nutraceuticals, and personal care sectors.

ZWGTL is a wholly owned subsidiary of ZWID, which holds 100% of its share capital. The incorporation is not classified as a related party transaction, and no promoter or group companies other than ZWID have an interest in the new entity. The subsidiary is yet to commence operations, and its turnover is currently nil. No specific governmental or regulatory approvals were required for this incorporation, and the consideration for the acquisition was in the form of cash.

Key Details of Zydus Wellness General Trading DWC-LLC

The share capital of Zydus Wellness General Trading DWC-LLC stands at AED 300,000, divided into 300,000 shares of AED 1 each. The following table summarises the key particulars of the newly incorporated entity:

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The strategic expansion through ZWGTL aligns with the company's objective to grow its presence in the wellness sector internationally.